Nuveen
VCYT icon

Nuveen’s Veracyte VCYT Stock Holding History

Nuveen’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Buy
439,120
+200,681
+84% +$8.42M 0.01% 1100
2026
Q1 		$7.68M Sell
238,439
-343,835
-59% -$12.7M ﹤0.01% 1704
2025
Q4 		$24.5M Sell
582,274
-139,275
-19% -$5.61M 0.01% 1024
2025
Q3 		$24.8M Sell
721,549
-108,049
-13% -$3.1M 0.01% 1018
2025
Q2 		$22.4M Sell
829,598
-283,474
-25% -$8.21M 0.01% 1027
2025
Q1 		$33M Sell
1,113,072
-81,320
-7% -$3.1M 0.01% 821
2024
Q4 		$47.3M Buy
1,194,392
+8,797
+0.7% +$333K 0.01% 674
2024
Q3 		$40.4M Buy
1,185,595
+472,901
+66% +$13.3M 0.01% 763
2024
Q2 		$15.4M Sell
712,694
-314,733
-31% -$6.62M ﹤0.01% 1304
2024
Q1 		$22.8M Buy
1,027,427
+5,148
+0.5% +$126K 0.01% 1107
2023
Q4 		$28.1M Sell
1,022,279
-75,003
-7% -$1.81M 0.01% 928
2023
Q3 		$24.5M Buy
1,097,282
+165,505
+18% +$4.26M 0.01% 930
2023
Q2 		$23.7M Buy
931,777
+697
+0.1% +$16.9K 0.01% 972
2023
Q1 		$20.8M Buy
931,080
+651,413
+233% +$15.7M 0.01% 1023
2022
Q4 		$6.64M Buy
279,667
+14,971
+6% +$348K ﹤0.01% 1753
2022
Q3 		$4.39M Sell
264,696
-5,245
-2% -$118K ﹤0.01% 1977
2022
Q2 		$5.37M Buy
269,941
+1,047
+0.4% +$21.2K ﹤0.01% 1894
2022
Q1 		$7.32M Sell
268,894
-5,111
-2% -$146K ﹤0.01% 1839
2021
Q4 		$11M Sell
274,005
-206,343
-43% -$9.12M ﹤0.01% 1631
2021
Q3 		$24.6M Buy
480,348
+45,214
+10% +$1.97M 0.01% 1127
2021
Q2 		$17.4M Sell
435,134
-41,068
-9% -$1.76M 0.01% 1481
2021
Q1 		$25.6M Sell
476,202
-51,943
-10% -$2.99M 0.01% 1138
2020
Q4 		$25.8M Sell
528,145
-3,227
-0.6% -$150K 0.01% 1081
2020
Q3 		$17.3M Buy
531,372
+183,168
+53% +$5.82M 0.01% 1151
2020
Q2 		$9.02M Sell
348,204
-81,789
-19% -$2.04M ﹤0.01% 1546
2020
Q1 		$10.5M Sell
429,993
-121,412
-22% -$3.06M 0.01% 1263
2019
Q4 		$15.4M Sell
551,405
-572,661
-51% -$14.8M 0.01% 1325
2019
Q3 		$27M Sell
1,124,066
-51,131
-4% -$1.36M 0.01% 971
2019
Q2 		$33.5M Buy
+1,175,197
New +$29.4M 0.01% 882

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nuveen's VCYT Position: Q2 2026 in Review

Nuveen increased its Veracyte (VCYT) stake by 84% in Q2 2026, buying an estimated $8.42M and bringing the position to 439,120 shares worth $25.8M. The position accounts for 0.01% of the portfolio, ranked #1100.

Nuveen first reported a position in VCYT in Q2 2019 and has held it in 29 quarters since. The position peaked at $47.3M in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Nuveen held 439,120 shares of Veracyte worth $25.8M as of Q2 2026.
  • Nuveen bought 200,681 Veracyte shares in Q2 2026, an estimated $8.42M.
  • Veracyte made up 0.01% of Nuveen's portfolio in Q2 2026, its #1100 holding.
  • Nuveen first reported a position in Veracyte in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Veracyte position peaked at $47.3M in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.